The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Oxford AHSN Strategyzer workshops helps companies shape their offering to be in-line with NHS needs
The Oxford AHSN Strategyzer half to one day workshops are run for companies that have a product or innovation and want to explore the viability of their concept for the NHS or want to move into the NHS market.
Diagnostic tests trialled in community hospital proved to ease winter pressure and increase efficiency
Wokingham Community Hospital purchased two different Point of Care (POC) diagnostic test devices for their elderly in-patient unit and wanted to evaluate the impact of attaining results more quickly and understand how it could help the nurses make effective decisions regarding treatment. The Oxford AHSN assisted by reporting the economic cost-consequence analysis of the two tests, determining what the cost benefit would be to the hospital by using Point of Care testing and extrapolate the benefits to the other community hospitals. QuickRead Go CRP is a rapid blood test for the quantitative determination of C-reactive protein that shows if there is inflammation or infection in the body. Alinity i-STAT is a portable blood testing machine with a cartridge for urea and electrolytes (U&E) that the nurses used to assess the kidney function of the patient. The tests enabled healthcare professionals to rapidly diagnose patients, and the greatest benefit came in knowing which patients did not need to be sent to the local Emergency Department (ED).
Feasibility study for introducing a new rapid point-of-care HIV test into sexual health clinics
Owen Mumford is a global leader in medical device design and manufacturing who worked with the Oxford AHSN to explore the advantages of introducing a new rapid point of care HIV test, which has a simple sample collection system and provides a prompt result to help support the early diagnosis of HIV.
AI technology speeds up stroke care and reduces costs
New artificial intelligence (AI)-driven imaging support software which has the potential to deliver huge benefits to hundreds of stroke patients each year and significant cost savings to the NHS has been implemented at the Royal Berkshire NHS Foundation Trust (RBH). The Oxford AHSN is supporting wider regional roll-out backed by NHS England. The CE-marked e-Stroke Suite developed by Brainomix Ltd includes tools for non-contrast CT and CT angiography brain scans, connecting physicians and facilitating information transfer. The software supports physicians in identifying patients who would benefit from acute stroke treatments, selecting patients most likely to benefit from specific interventions, such as mechanical thrombectomy.
Can using point of care blood tests help inform decision making in patients over 65 presenting with acute frailty syndrome?
UK ambulance services have been identified as potential beneficiaries of point of care testing (POCT) to guide patient management and care pathways, but there is little published evidence on the uses, benefits and health economics of POCT in pre-hospital settings. The Oxford AHSN, along with eight specialist paramedics based at the Royal Berkshire Hospital in Reading, conducted a quality improvement study to look at utilising POCT to aid decision-making in patients aged over 65 presenting to South Central Ambulance Service with acute frailty syndrome.
Unique point of care blood test speeds up clinical decision-making, improves quality of care and reduces costs
A new point of care blood testing device is being introduced into frontline NHS services after an evaluation at three hospitals showed that it reduced A&E waiting times and helped clinicians make quicker decisions and get it right first time.
The Oxford AHSN assists Fujifilm in real-world evaluation of point of care flu test
A new point of care test for the detection of flu is in the process of being commissioned by Buckinghamshire Healthcare after a winter evaluation in the Acute Medical Unit (AMU) at Stoke Mandeville Hospital. The test was developed by Fujifilm Medical Systems and is based on silver-amplified lateral flow technology in a simple cartridge with an automated reader.
Thousands more pregnant women benefit from test to rule out pre-eclampsia following national rollout led by the Oxford AHSN
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country. Rapid uptake means these tests are becoming available to thousands more pregnant women – up from 29,000 in March 2019 to a predicted 200,000+ by the end of December 2019. The award-winning NHS/research/industry partnership has been selected for the NHS England Accelerated Access Collaborative, Innovation Technology Payment and Rapid Uptake programmes in 2019/20 which introduce an accelerated pathway to market for highly transformative innovations.
CanSense and Dravya Discovery each receive £50,000 investment through Oxford AHSN Accelerator programme
The Oxford AHSN Accelerator programme, in collaboration with BioCity and regional partners from the NHS, industry and research within the Thames Valley, offers a launchpad for entrepreneurs and their ventures to move from idea to market. CanSense and Dravya Discovery won a place on the intensive eight-week programme and pitched to investors on the final day of the Accelerator programme in November 2019.
Physiomics - Virtual Tumour™
Physiomics has developed a proprietary modelaided simulation of tumours, Virtual Tumour™, to help pharmaceutical companies improve the success rate of drug development.
CareHound by Consentricare
CareHound is a free mobile app for people organising elderly care, designed by Consentricare, a healthtech start-up launched by two friends, after experiencing difficulties accessing information and organising social care for their elderly parents. Nearly 1.4 million older people in the UK are missing out on the care they need, due to difficulties in accessing information about what is available to them.
Funded by an Innovate UK grant, the Oxford AHSN is working with Osler Diagnostics, a health technology company developing innovative biosensor technology and products. Osler’s main product is a portable, handheld device capable of taking a drop of blood and quickly testing for a panel of biomarkers.